Blenrep
- Product NDC
- 0173-0913
- 11-digit product format
- 001730913
- Labeler code
- 0173
- Product ID
- 0173-0913_aef7c34c-fef8-407c-99c0-a68aded53c60
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- belantamab mafodotin
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- GlaxoSmithKline LLC
- Application
- BLA761440
- Marketing category
- BLA
- Marketing start
- 2025-10-23
- Substance
- BELANTAMAB MAFODOTIN
- Active strength
- 50 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Blenrep
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BELANTAMAB MAFODOTIN | 50 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | DB1041CXDG |
| Rxcui | 2725585, 2725587 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0173-0913-01 | Blenrep | 1.4 mL in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1.4 | | 1 |
| 0173-0913-01 | Blenrep | 1 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 1 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0173-0913-01 | 00173091301 | 1 VIAL in 1 CARTON (0173-0913-01) / 1.4 mL in 1 VIAL | 1 vial | 2025-10-23 | No | No | Current |